Pregnancy and diabetic retinopathy: assessment and treatment
Keywords:
diabetic retinopathy, pregnancy, laser photocoagulation, intravitreal steroids, anti-VEGFAbstract
The prevalence of diabetic retinopathy (DR) continues to increase in pregnant women. The lack of studies on the safety and efficacy of current treatment options during pregnancy makes management of the disease particularly challenging. All pregnant women with diabetes should undergo prenatal screening for DR as well as receive advice on the course and management of DR during pregnancy. Optimal control of blood glucose and blood pressure should be recommended. For patients with proliferative diabetic retinopathy (PDR) in the absence of significant diabetic macular edema (DME), pan-retinal photocoagulation remains a safe and effective treatment option. Significant diabetic macular edema can be treated with a focal laser if focal leakage areas are identified in the macula, intravitreally introduced steroids or anti-VEGF agents. The theoretical risk of anti-VEGF agents to the fetus must be considered so patients should be informed of the risks and benefits of anti-VEGF therapy before treatment is initiated. When deciding to treat with anti-VEGF agents, Ranibizumab should be the agent of choice. In conclusion, ophthalmologists should make treatment decisions in pregnant patients with DR on a case-by-case basis, taking into account disease severity, risk of permanent vision loss, gestational term, and patient preferences.
References
1. WIDYAPUTRI, F., ROGERS, S.L., KANDASAMY, R. et al. Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis. In: JAMA Ophthalmol. 2022, nr. 140, pp. 486-94. https://doi.org/10.1001/jamaophthalmol.2022.0050
2. MORRISON, J.L., HODGSON, L.A., LIM, L.L., et al. Diabetic retinopathy in pregnancy: a review. In: Clin Exp Ophthalmol. 2016, nr. 44 pp. 321-34. https://doi.org/10.1111/ceo.12760
3. WIDYAPUTRI, F., ROGERS, S.L., KHONG, E.W.C., et al. Prevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum. In: Clin Exp Ophthalmol. 2022, nr. 50, pp. 757-67. https://doi.org/10.1111/ceo.14111
4. EGAN, A.M., MCVICKER, L., HEEREY, A., et al. Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes. In: J Diabetes Res. 2015, 310239. https://doi.org/10.1155/2015/310239
5. CHRISTINA, J.F., et al. Diabetic Retinopathy Preferred Practice Pattern. Available online https://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp
6. AMERICAN DIABETES ASSOCIATION PROFESSIONAL PRACTICE COMMITTEE. Introduction and Methodology: Standards of Care in Diabetes-2024. In: Diabetes Care. 2024 nr. 1, pp. 47(Supplement_1):S1-S4. https://doi.org/10.2337/dc24-SINT
7. NICE Clinical Guideline 63. Diabetes in pregnancy: management of diabetes and its complication from pre-conception to the postnatal period. Available online: https://www.ascalema.es/wp-content/uploads/2014/08/011KO_Diabetes-in-pregnancy-2008.pdf
8. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. In: Diabetes Care. 2000, nr. 23, pp. 1084-91. https://doi.org/10.2337/diacare.23.8.1084
9. RASMUSSEN, K.L, LAUGESEN, C.S., RINGHOLM, L., et al. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. In: Diabetologia. 2010, nr. 53, pp. 1076-83. https://doi.org/10.1007/s00125-010-1697-9
10. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. In: Arch Ophthalmol. 1998, nr. 116, pp. 874-86. https://doi.org/10.1001/archopht.116.7.874
11. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. In: Ophthalmology. 1991, nr. 98, pp. 786-806. https://doi.org/10.1016/S0161-6420(13)38012-9
12. WANG, Y.T, TADARATI, M, WOLFSON, Y., et al. Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography. In: JAMA Ophthalmol. 2016;134:222-8. https://doi.org/10.1001/jamaophthalmol.2015.5332
13. FRIBERG, T.R., GUPTA, A., YU, J., et al. Ultrawide angle fluorescein angiographic imaging: a comparison to conventional digital acquisition systems. In: Ophthalmic Surg Lasers Imaging. 2008, nr. 39, pp. 304-11. https://doi.org/10.3928/15428877-20080701-06
14. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Fluorescein. [Updated 2021 Dec 20].
15. SPAIDE, R.F., FUJIMOTO, J.G., WAHEED, N.K., et al. Optical coherence tomography angiography. In: Prog Retin Eye Res. 2018, nr. 64, pp. 1-55. https://doi.org/10.1016/j.preteyeres.2017.11.003
16. CHEW, E.Y., MILLS, J.L., METZGER, B.E. et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. In: Diabetes Care. 1995, nr. 18, pp. 631-7. https://doi.org/10.2337/diacare.18.5.631
17. BAKER, C.W., GLASSMAN, A.R., BEAULIEU, W.T., et al. Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. In: JAMA. 2019, nr. 321:1880-94. https://doi.org/10.1001/jama.2019.5790
18. WELLS, J.A., GLASSMAN, A.R., AYALA, A.R., et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. In: N Engl J Med. 2015, nr. 372, pp. 1193-203. https://doi.org/10.1056/NEJMoa1414264
19. SCOTT, I.U., DANIS, R.P., BRESSLER, S.B., et al. Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. In: Retina. 2009, nr. 29, pp. 613-7. https://doi.org/10.1097/IAE.0b013e3181a2c07a
20. SCHWARTZ, S.G., FLYNN, H.W., SCOTT, I.U. Intravitreal Corticosteroids in the Management of Diabetic Macular Edema. In: Curr Ophthalmol Rep. 2013 nr. 1: https://doi.org/10.1007/s40135-013-0015-3
21. CONCILLADO, M., LUND-ANDERSEN, H., MATHIESEN, E.R., et al. Dexamethasone Intravitreal Implant for Diabetic Macular Edema During Pregnancy. In: Am J Ophthalmol. 2016, nr. 165, pp. 7-15. https://doi.org/10.1016/j.ajo.2016.02.004
22. Regeneron product information (aflibercept) 2015. [Citat 15.07.2024] Available online: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125387lbl.pdf
23. ALMAWI, W.Y., SALDANHA, F.L., MAHMOOD, N.A., et al. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. In: Hum Reprod. 2013, nr. 28, pp. 2628-35. https://doi.org/10.1093/humrep/det308
24. ZEHETNER, C., KRALINGER, M.T., MODI, Y.S., et al. Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial. In: Acta Ophthalmol. 2015, nr. 93: e154-9. https://doi.org/10.1111/aos.12604
25. SARMAD, A., LIP, P.L. Intravitreal anti-vascular endothelial growth factor in early pregnancy and the complex management of advance diabetic retinopathy and maculopathy during pregnancy. In: Acta Ophthalmol. 2016, nr. 94, e812-3. https://doi.org/10.1111/aos.13083
26. SULLIVAN, L., KELLY, S.P., GLENN, A., et al. Intravitreal bevacizumab injection in unrecognised early pregnancy. In: Eye (Lond). 2014, nr. 28, pp. 492-4. https://doi.org/10.1038/eye.2013.311
27. CHENG, A.Y. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. In: Can J Diabetes. 2013, nr. 37, pp. S1-3. https://doi.org/10.1016/j.jcjd.2013.04.005
28. CHAN, W.C., LIM, L.T., QUINN, M.J. et al. Management and outcome of sight-threatening diabetic retinopathy in pregnancy. In: Eye (Lond). 2004, nr. 18, pp. 826-32. https://doi.org/10.1038/sj.eye.6701340
29. ABDELAAL, A.M., ALQAHTANI, A.S. Mode of Delivery in the Setting of Repeated Vitreous Hemorrhages in Proliferative Diabetic Retinopathy: A Case Report and Review of the Literature. In: Cureus. 2020, nr. 12, pp. e11239 https://doi.org/10.7759/cureus.11239
30. MIR, T.A., FINN, A.P. Pregnancy and diabetic retinopathy considerations for evaluation and treatment: a review. In: Ann Eye Sci. 2023, nr. 8:14. https://doi.org/10.21037/aes-22-82
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
